Hi Mr daeff,
gsk used to report in their quarterlies that approval was pending. They seem to have given up saying that now. But as far as I am aware, all is good.
They have produced enough great data. It's crazy when one thinks about how much better it has been proved to be!
Arixtra is the best!
- Forums
- ASX - By Stock
- TSN
- southern cross - biotech report
southern cross - biotech report, page-7
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable